Lexaria Bioscience Corp. (LEXX)
0.5416
-0.02
(-3.29%)
USD |
NASDAQ |
Dec 30, 16:00
0.53
-0.01
(-2.14%)
After-Hours: 18:07
Lexaria Bioscience Market Cap: 13.48M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 95.76M |
| Aurinia Pharmaceuticals, Inc. | 2.084B |
| Edesa Biotech, Inc. | 10.61M |
| Xenon Pharmaceuticals, Inc. | 3.411B |
| ProMIS Neurosciences, Inc. | 14.85M |
Market Cap Related Metrics
| PS Ratio | 13.82 |
| PEG Ratio | -0.0183 |
| Price to Book Value | 4.509 |
| Price | 0.5416 |
| Earnings Yield | -122.2% |
| PEGY Ratio | -0.0183 |